John Didsbury, PhD

JAD profile

Affiliation(s): 

T3D Therapeutics; Inc.

Areas of Interest: 

Alzheimer's disease, Huntington's disease, drug development

Biography & Research: 

Thorough knowledge of the drug development process, strategies and commercial assessments with leadership roles in both public and private small, medium and large pharmaceutical companies spanning 25+ years. Prior tenure as Head of Strategy and Operations for one of 6 worldwide drug discovery centers at a major pharmaceutical company provides the pharmaceutical drug development expertise necessary to manage and integrate all functions needed to advance a candidate drug to market; i.e. research, clinical, regulatory, commercial, legal. Direct drug discovery and development program management, as Chief Scientific Officer, of both pre-clinical and clinical programs, including a Phase 2 clinical trial for Chemotherapy-Induced Neuropathic Pain, a Phase 2 clinical trial for Alzheimer’s Disease and successful IND submissions for a novel Type 2 Diabetes drug and Alzheimer’s drug.